New cream targets root cause of devastating skin disease
Disease control
Completed
This study tested a new skin cream called SXR1096 for people with Netherton Syndrome, a rare and severe genetic skin condition with no specific treatment. For one month, participants applied the active cream and a placebo cream to different areas of their skin. The main goals wer…
Phase: PHASE1, PHASE2 • Sponsor: Sixera Pharma • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC